Lenalidomide and Idelalisib in Treating Patients With Recurrent Follicular Lymphoma

NCT01644799 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Follicular Lymphoma

Interventions

DRUG: idelalisib
DRUG: lenalidomide

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]
[object Object]
[object Object]